d-Penicillamine-Induced ANCA-Associated Crescentic Glomerulonephritis in Wilson Disease

American Journal of Kidney Diseases

Volumn 50, Issue 5, 2007, Pages 821-825

  Bienaimé, Frank ^a   Clerbaux, Gaétan ^a   Plaisier, Emmanuelle ^a   Mougenot, Béatrice ^a   Ronco, Pierre ^a   Rougier, Jean Philippe ^a  

^a HÔPITAL TENON   (France)

Author keywords

Antineutrophil cytoplasmic antibody (ANCA) induced glomerulonephritis; d penicillamine; Wilson disease

Indexed keywords

ANTIBODY; MYELOPEROXIDASE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENICILLAMINE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FUNCTION; NEPHRITIS; NEPHROLOGY; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; THORAX RADIOGRAPHY; WILSON DISEASE;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHELATING AGENTS; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS; GLUCOCORTICOIDS; HEPATOLENTICULAR DEGENERATION; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; METHYLPREDNISOLONE; NECROSIS; PENICILLAMINE; PEROXIDASE; VASCULITIS;

EID: 35348834743     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.05.026     Document Type: Article

References (46)

1. Merkel P.A. Drug-induced vasculitis. Rheum Dis Clin North Am 27 (2001) 849-862
2. Meyboom R.H.B., and Brodie-Meijer C.C.E. Metal antagonists. In: Dukes M.N.G. (Ed). Meyler's Side Effects of Drugs (2000), Elsevier Science, Oslo, Norway 723-753
3. Hall C.L., Jawad S., Harrison P.R., et al. Natural course of penicillamine nephropathy: A long term study of 33 patients. Br Med J 296 (1988) 1083-1086
4. Endo H., Hosono T., and Kondo H. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 21 (1994) 864-870
5. Messiaen T., M'Bappe P., Boffa J.J., et al. MPO-ANCA necrotizing glomerulonephritis related to rheumatoid arthritis. Am J Kidney Dis 32 (1998) E6
6. Gitlin J.D. Wilson disease. Gastroenterology 125 (2003) 1868-1877
7. Walshe J.M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med 21 (1956) 487-495
8. Sternlieb I., Bennett B., and Scheinberg I.H. d-Penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med 82 (1975) 673-676
9. Sarles J., Durand J.M., Scheiner C., and Picon G. Wilson disease, IgA glomerulonephritis and vascular purpura: An incidental association?. Arch Fr Pediatr 50 (1993) 501-504
10. Garcia-Porrua C., Gonzalez-Gay M.A., and Bouza P. d-Penicillamine-induced crescentic glomerulonephritis in a patient with scleroderma. Nephron 84 (2000) 101-102
11. Marchand-Courville S., Dhib M., Fillastre J.P., and Godin M. Extracapillary glomerulonephritis secondary to d-penicillamine. Apropos of 1 case and review of the literature. Nephrologie 19 (1998) 25-32
12. Locke I.C., Worrall J.G., Leaker B., Black C.M., and Cambridge G. Autoantibodies to myeloperoxidase in systemic sclerosis. J Rheumatol 24 (1997) 86-89
13. Chalmers A., Thompson D., Stein H.E., Reid G., and Patterson A.C. Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis. Ann Intern Med 97 (1982) 659-663
14. Gibson T., Burry H.C., and Ogg C. Goodpasture syndrome and d-penicillamine. Ann Intern Med 84 (1976) 100 (letter)
15. Falck H.M., Tornroth T., Kock B., and Wegelius O. Fatal renal vasculitis and minimal change glomerulonephritis complicating treatment with penicillamine. Report on two cases. Acta Med Scand 205 (1979) 133-138
16. Gavaghan T.E., McNaught P.J., Ralston M., and Hayes J.M. Penicillamine-induced "Goodpasture's syndrome": Successful treatment of a fulminant case. Aust N Z J Med 11 (1981) 261-265
17. Omote A., Muramatsu M., Sugimoto Y., et al. Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies-related scleroderma renal crisis treated with double-filtration plasmapheresis. Intern Med 36 (1997) 508-513
18. Swainson C.P., Thomson D., Short A.I., and Winney R.J. Plasma exchange in the successful treatment of drug-induced renal disease. Nephron 30 (1982) 244-249
19. Hasselmann M., Maurier F., Lutun P., Vetter J.M., and Tempe J.D. Goodpasture's syndrome in rheumatoid arthritis treated with d-penicillamine. Rev Med Interne 3 (1982) 237-238
20. Banfi G., Imbasciati E., Guerra L., Mihatsch M.J., and Ponticelli C. Extracapillary glomerulonephritis with necrotizing vasculitis in d-penicillamine-treated rheumatoid arthritis. Nephron 33 (1983) 56-60
21. Sadjadi S.A., Seelig M.S., Berger A.R., and Milstoc M. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage d-penicillamine. Am J Nephrol 5 (1985) 212-216
22. Bonan G., Caubarrere I., Beaufils H., Lucsko M., and Aubert P. Diffuse alveolar hemorrhage and severe glomerulonephritis induced by d-penicillamine. Apropos of a case report with review of the literature. Therapie 41 (1986) 297-298
23. Ntoso K.A., Tomaszewski J.E., Jimenez S.A., and Neilson E.G. Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: Successful treatment of two patients and a review of the literature. Am J Kidney Dis 8 (1986) 159-163
24. Williams A.J., Fordham J.N., Barnes C.G., and Goodwin F.J. Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with d-penicillamine. Ann Rheum Dis 45 (1986) 82-84
25. Devogelaer J.P., Pirson Y., Vandenbroucke J.M., Cosyns J.P., Brichard S., and Nagant de Deuxchaisnes C. d-Penicillamine induced crescentic glomerulonephritis: Report and review of the literature. J Rheumatol 14 (1987) 1036-1041
26. Peces R., Riera J.R., Arboleya L.R., Lopez-Larrea C., and Alvarez J. Goodpasture's syndrome in a patient receiving penicillamine and carbimazole. Nephron 45 (1987) 316-320
27. Lauque D., Courtin J.P., Fournie B., Oksman F., Pourrat J., and Carles P. Pneumorenal syndrome induced by d-penicillamine: Goodpasture's syndrome or microscopic polyarteritis?. Rev Med Interne 11 (1990) 168-171
28. Jones B.F., and Major G.A. Crescentic glomerulonephritis in a patient taking penicillamine associated with antineutrophil cytoplasmic antibody. Clin Nephrol 38 (1992) 293
29. Macarron P., Garcia Diaz J.E., Azofra J.A., et al. d-Penicillamine therapy associated with rapidly progressive glomerulonephritis. Nephrol Dial Transplant 7 (1992) 161-164
30. Almirall J., Alcorta I., Botey A., and Revert L. Penicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis. Am J Nephrol 13 (1993) 286-288
31. Donnelly S., Levison D.A., and Doyle D.V. Systemic lupus erythematosus-like syndrome with focal proliferative glomerulonephritis during D-penicillamine therapy. Br J Rheumatol 32 (1993) 251-253
32. Gaskin G., Thompson E.M., and Pusey C.D. Goodpasture-like syndrome associated with anti-myeloperoxidase antibodies following penicillamine treatment. Nephrol Dial Transplant 10 (1995) 1925-1928
33. Mathieson P.W., Peat D.S., Short A., and Watts R.A. Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine. Nephrol Dial Transplant 11 (1996) 863-866
34. Karpinski J., Jothy S., Radoux V., Levy M., and Baran D. d-Penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature. Am J Nephrol 17 (1997) 528-532
35. Marlier S., Gisserot O., Yao N., et al. Extra-capillary glomerulonephritis induced by d-penicillamine therapy. Presse Med 28 (1999) 689-690
36. Kyndt X., Ducq P., Bridoux F., et al. Extracapillary glomerulonephritis with anti-myeloperoxidase antibodies in 2 patients with systemic scleroderma treated with penicillamine D. Presse Med 28 (1999) 67-70
37. Nanke Y., Akama H., Terai C., and Kamatani N. Rapidly progressive glomerulonephritis with d-penicillamine. Am J Med Sci 320 (2000) 398-402
38. Derk C.T., and Jimenez S.A. Goodpasture-like syndrome induced by d-penicillamine in a patient with systemic sclerosis: Report and review of the literature. J Rheumatol 30 (2003) 1616-1620
39. Hsieh H.S., Chang C.F., Yang A.H., Kuo H.L., Yang W.C., and Lin C.C. Antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis associated with rheumatoid arthritis: An unusual case report. Nephrology (Carlton) 8 (2003) 243-247
40. Harper L., Cockwell P., Howie A.J., et al. Focal segmental necrotizing glomerulonephritis in rheumatoid arthritis. QJM 90 (1997) 125-132
41. Anders H.J., Wiebecke B., Haedecke C., Sanden S., Combe C., and Schlondorff D. MPO-ANCA-positive crescentic glomerulonephritis: A distinct entity of scleroderma renal disease?. Am J Kidney Dis 33 (1999) E3
42. Suganuma T. Glomerular IgA deposits in an autopsy study. Nippon Jinzo Gakkai Shi 36 (1994) 813-822
43. Waldherr R., Rambausek M., Duncker W.D., and Ritz E. Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant 4 (1989) 943-946
44. Cuperus R.A., Muijsers A.O., and Wever R. Antiarthritic drugs containing thiol groups scavenge hypochlorite and inhibit its formation by myeloperoxidase from human leukocytes. A therapeutic mechanism of these drugs in rheumatoid arthritis?. Arthritis Rheum 28 (1985) 1228-1233
45. Goldman M., Druet P., and Gleichmann E. TH2 cells in systemic autoimmunity: Insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 12 (1991) 223-227
46. Doyle M.K., and Cuellar M.L. Drug-induced vasculitis. Expert Opin Drug Saf 2 (2003) 401-409